Cas:1086399-13-4 Spiro[2.5]octane-6-carboxylic acid manufacturer & supplier

Chemical Name:Spiro[2.5]octane-6-carboxylic acid

CAS.NO:1086399-13-4

Synonyms:qc-2679

Molecular Formula:C₉H₁₄O₂

Molecular Weight:154.20600

HS Code:2916209090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:37.30000

Exact Mass:154.09900

LogP:2.04140

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like qc-2679 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,qc-2679 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,qc-2679 Use and application,qc-2679 technical grade,usp/ep/jp grade.

Related News: In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. Spiro[2.5]octane-6-carboxylic acid manufacturer ��Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.�� Spiro[2.5]octane-6-carboxylic acid supplier Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease. Spiro[2.5]octane-6-carboxylic acid vendor Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). Spiro[2.5]octane-6-carboxylic acid factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.